|
|
|||||||||||||||||||||||||||||||||
|
TABLE-6
Above table shows that there was marked improvement in subjective symptoms. Besides this, a better sense of well being was observed in all the patients. On the basis of the above result this can be concluded that Episulin can also be in Insulin Dependent Diabetes Mellitus (IDDM) as an adjuvant which in turn will be helpful in reducing the dosage of Insulin and other hypoglycaemic drugs. Marked improvement in symptoms along with a better sense of well being was experienced by all the patients. This may be due to better glycaemic control exerted by Episulin or we may say that these are the specific Ayurvedic natural constituents of Episulin Which is addition to adequate glycamic control induces a better sense of well being. PRESENTATION: Strips of 10 capsules. |
|||||||||||||||||||||||||||||||||
|
||
Home
|| Preface || Formulation
|| Standardization || Effects
|| Safety || Subjective
Sympton ||
|
|||||||||||||||||||||||||||||||||